scholarly journals The synthesis, oxidation and characterization of GLP-1 peptide receptor fragments

2018 ◽  
Author(s):  
János Szolomájer ◽  
Zoltán Kele ◽  
Gábor K. Tóth ◽  
Pál Stráner ◽  
András Perczel
Analgesia ◽  
1999 ◽  
Vol 4 (1) ◽  
pp. 27-32 ◽  
Author(s):  
John S. Partilla ◽  
F. Ivy Carrol ◽  
James B. Thomas ◽  
Kenner C. Rice ◽  
Dennis M. Zimmerman ◽  
...  

Genomics ◽  
2004 ◽  
Vol 84 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Hideki Sano ◽  
Scott D Feighner ◽  
Donna L Hreniuk ◽  
Hisashi Iwaasa ◽  
Andreas W Sailer ◽  
...  

Blood ◽  
1987 ◽  
Vol 70 (3) ◽  
pp. 860-868
Author(s):  
CW Distelhorst ◽  
KE Janiga ◽  
KJ Howard ◽  
SE Strandjord ◽  
EJ Campbell

Characterization of glucocorticoid receptors in leukemia cells is important to understand mechanisms of glucocorticoid resistance but has been impeded by receptor fragmentation in cytosol extracts. We recently found that formation of 52- and 30-kilodalton (kD) glucocorticoid receptor fragments in cytosol of leukemia cells is due to proteolysis and is blocked by diisopropylfluorophosphate (DFP). In the present study, we identify a 28-kD serine protease in cytosol of leukemia cells that binds [3H]DFP and correlates with the formation of 52- and 30-kD receptor fragments. This protease is immunoprecipitated by antiserum to neutrophil elastase. Limited digestion of [3H]dexamethasone-21-mesylate- labeled receptors by purified neutrophil elastase produces 52- and 30- kD receptor fragments. Receptor fragmentation in the cytosol of leukemia cells in inhibited by methoxysuccinyl-alanyl-alanyl-prolyl- valyl-chloromethylketone, a highly specific inhibitor of neutrophil elastase. The addition of as few as 5% neutrophils to a lymphoid cell suspension provides sufficient elastase to produce receptor fragmentation. Our findings indicate that neutrophil elastase is responsible for receptor fragmentation in the cytosol of leukemia cells. The neutrophil elastase may be endogenous to the leukemia cells or may come from neutrophils that contaminate leukemia cell suspensions.


1999 ◽  
Vol 85 (9) ◽  
pp. 796-802 ◽  
Author(s):  
V. Bodart ◽  
J. F. Bouchard ◽  
N. McNicoll ◽  
E. Escher ◽  
P. Carrière ◽  
...  

Blood ◽  
1984 ◽  
Vol 63 (3) ◽  
pp. 588-592 ◽  
Author(s):  
MC Benyunes ◽  
R Snyderman

Abstract The study of chemoattractant receptors on human monocytes had been limited by the lack of a radioligand suitable for use with the small numbers of cells routinely available from human donors. A new synthetic oligopeptide radioligand f[35S]met-leu-phe, with a higher specific radioactivity than was available with the tritiated compound, was used to characterize a chemoattractant receptor on freshly isolated human blood monocytes. These cells bind f[35S]met-leu-phe with a dissociation constant (KD) of 30.2 +/- 5.6 nM and contain 84,000 +/- 11,300 receptors per cell. f[35S]met-leu-phe does not bind specifically to blood lymphocytes. The specificity of the oligopeptide receptor on monocytes is indistinguishable from the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. Using f[35S]met-leu- phe, it will now be feasible to study the chemotactic peptide receptor on small numbers of partially purified peripheral blood monocytes from patients with defects of immune function.


Gene ◽  
1995 ◽  
Vol 162 (2) ◽  
pp. 181-188 ◽  
Author(s):  
Edwin Roovers ◽  
Muriel E. Vincent ◽  
Ellen van Kesteren ◽  
Wijnand P.M. Geraerts ◽  
Rudi J. Planta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document